Literature DB >> 29064274

Effects of birth weight on profiles of dried blood amino-acids and acylcarnitines.

Lili Yang1, Yu Zhang1, Jianbin Yang1, Xinwen Huang1.   

Abstract

Background Birth weight influences profiles of dried blood amino-acids and acylcarnitines in newborn screening. This study aimed to define a more appropriate cut-off value to reduce the false positive rate and the number of recalled patients in newborn screening. Methods All babies who underwent newborn screening in our center were included; they were divided into groups by birth weight: 2500-3999 g (comparator group), <1000 g (group 1), 1000-1499 g (group 2), 1500-2499 g (group 3), and >4000 g (group 4). The 0.5th and 99.5th percentiles were used as the cut-off values. Comparisons were done on amino acid and acylcarnitines concentrations between the groups. False positive rate, positive predictive value, corrected false positive rate by birth weights were determined. Results Data on a total of 578,287 newborn infants were included in the analysis. The total false positive rate was 0.75%, and positive predictive value 2.89%. The false positive rate was 0.69%, 0.54% and 5.31% in infants with normal birth weight, birth weight of >4000 (group 4) and low birth weight of < 2500 g (groups 1, 2 and 3), respectively. Low-birth weight infants had much higher phenylalanine, tyrosine, methionine, arginine, propionylcarnitine, isovalerylcarnitine and octadecanoylcarnitine concentrations. Free carnitines and palmitoylcarnitine concentrations were lower. After adjusting for birth weight, false positive rate of all indices decreased to 0.53%, and positive predictive value increased to 4.31%. Conclusions Amino acid and carnitine concentrations in low-birth weight newborn infants may differ from the normal term newborn infants. The cut-off values of individual metabolites should be adjusted based on birth weight, to reduce false positive rate and increase positive predictive value.

Entities:  

Keywords:  Tandem mass spectrometry; birth weight; false positive rate; newborn screening

Mesh:

Substances:

Year:  2017        PMID: 29064274     DOI: 10.1177/0004563216688038

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

1.  Application of the Artificial Intelligence Algorithm Model for Screening of Inborn Errors of Metabolism.

Authors:  Muping Zhou; Liyuan Deng; Yan Huang; Ying Xiao; Jun Wen; Na Liu; Yingchao Zeng; Hua Zhang
Journal:  Front Pediatr       Date:  2022-05-19       Impact factor: 3.569

2.  Does metabolomic profile differ with regard to birth weight?

Authors:  Harpa Vidarsdottir; Thordur Thorkelsson; Thorhallur Ingi Halldorsson; Ragnar Bjarnason; Reynir Tomas Geirsson; Piero Rinaldo; Leifur Franzson
Journal:  Pediatr Res       Date:  2020-06-29       Impact factor: 3.756

3.  Reference Standards for Newborn Screening of Metabolic Disorders by Tandem Mass Spectrometry: A Nationwide Study on Millions of Chinese Neonatal Populations.

Authors:  Falin He; Rulai Yang; Xinwen Huang; Yaping Tian; Xiaofang Pei; Mary Kathryn Bohn; Lin Zou; Yan Wang; Haibo Li; Ting Wang; Maosheng Gu; Tao Jiang; Xigui Chen; Hui Zou; Hongwei Wei; Weibing Tian; Tian Tang; Khosrow Adeli; Zhiguo Wang
Journal:  Front Mol Biosci       Date:  2021-12-16

4.  Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.

Authors:  Xinwen Huang; Dingwen Wu; Lin Zhu; Wenjun Wang; Rulai Yang; Jianbin Yang; Qunyan He; Bingquan Zhu; Ying You; Rui Xiao; Zhengyan Zhao
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

5.  Prediction of an outcome using NETwork Clusters (NET-C).

Authors:  Jai Woo Lee; Jie Zhou; Erika L Moen; Tracy Punshon; Anne G Hoen; Megan E Romano; Margaret R Karagas; Jiang Gui
Journal:  Comput Biol Chem       Date:  2020-12-08       Impact factor: 2.877

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.